Home ETF List About

Portfolio Holdings Detail for ISIN IE0031442068
Stock Name / FundiShares Core S&P 500 UCITS ETF USD (Dist)
IssuerBlackrock
Entity holding fund iShares Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300YDM1GFZR5B4U80
ETF TickerIDUS(USD) LSE
ETF TickerIDUS.LS(USD) CXE
ETF TickerIUSA.AS(EUR) CXE
ETF TickerIUSA.DE(EUR) CXE
ETF TickerIUSA.LS(GBX) CXE
ETF TickerIUSA.MI(EUR) CXE
ETF TickerIUSAz(USD) CXE
ETF TickerIUSA(EUR) ETF Plus
ETF TickerIDUS.L(GBP) LSE

Holdings detail for LLY

Stock NameEli Lilly and Company
TickerLLY(EUR) F
TYPECommon Stock
CountryGermany
ISINUS5324571083
LEIFRDRIPF3EKNDJ2CQJL29

Show aggregate LLY holdings

News associated with LLY

Notable Friday Option Activity: AMD, LLY, BKNG
Looking at options trading activity among components of the S&P 500 index, there is noteworthy activity today in Advanced Micro Devices Inc (Symbol: AMD), where a total volume of 570,924 contracts has been traded thus far today, a contract volume which is representative of a - 2025-09-19 14:45:00
Boost Your Portfolio With These Top-Ranked ETFs
With the Fed's first 2025 rate cut and upgraded growth outlook, ETFs in tech, financials, industrials and health care could benefit from momentum. - 2025-09-19 13:03:00
3 Dividend Growth Stocks You Can Buy and Forget About
Key PointsThese stocks offer seemingly low yields of less than 1%. - 2025-09-18 05:50:00
JPMorgan Chase & Co. Has Lowered Expectations for Eli Lilly and Company (NYSE:LLY) Stock Price
Eli Lilly and Company (NYSE:LLY – Get Free Report) had its price objective decreased by JPMorgan Chase & Co. from $1,100.00 to $1,050.00 in a research report issued on Tuesday,Benzinga reports. The brokerage presently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price target indicates a potential upside of 38.09% from the […] - 2025-09-18 02:56:56
Lilly's Orforglipron Achieves Significant Weight Loss In Phase 3 Trial
(RTTNews) - Eli Lilly and Co. (LLY) announced detailed results from its Phase 3 ATTAIN-1 trial, evaluating the safety and efficacy of orforglipron—an investigational oral glucagon-like peptide-1 (GLP-1) receptor agonist—in adults with obesity, or those overweight with a weight-re - 2025-09-17 00:35:16
XLV, LLY, TMO, PFE: Large Inflows Detected at ETF
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the The Health Care Select Sector SPDR Fund (Symbol: XLV) where we have detected an approximate $308.0 million dollar inflow -- that's a 0.9% increase we - 2025-09-16 11:47:58
S&P 500 Analyst Moves: LLY
The latest tally of analyst opinions from the major brokerage houses shows that among the components of the S&P 500 index, Eli Lilly is now the #61 analyst pick, moving up by 1 spot. This rank is formed by averaging the analyst opinions for each component from each - 2025-09-15 14:35:56
Why Novo Nordisk Stock Popped Today
Key PointsLondon's Financial Times highlights improved weight loss from taking more Ozempic. - 2025-09-15 12:34:46
Sen. John Boozman Buys Eli Lilly and Company (NYSE:LLY) Stock
Senator John Boozman (R-Arkansas) recently bought shares of Eli Lilly and Company (NYSE:LLY). In a filing disclosed on September 12th, the Senator disclosed that they had bought between $1,001 and $15,000 in Eli Lilly and Company stock on August 11th. Senator John Boozman also recently made the following trade(s): Purchased $1,001 – $15,000 in shares […] - 2025-09-15 03:12:42
3 Monster Stocks to Hold for the Next 5 Years
Key PointsAmazon should improve its profits and margins, based on its cloud computing and AI initiatives. - 2025-09-14 08:45:00
2 Beaten-Down Stocks to Buy and Hold Forever
Key PointsApple and Eli Lilly have impressive long-term track records of returns. - 2025-09-13 08:45:00
2 Monster Stocks to Hold for the Next 5 Years
Key PointsThese stocks have climbed in the triple digits over the past three years. - 2025-09-11 05:20:00
IWB, LLY, ORCL, CVX: Large Inflows Detected at ETF
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Russell 1000 ETF (Symbol: IWB) where we have detected an approximate $462.9 million dollar inflow -- that's a 1.1% increase week over week in - 2025-09-08 12:03:03
Down 34%, Should You Buy the Dip on Viking Therapeutics?
Key PointsViking Therapeutics is working on an injectable weight loss drug candidate and one in pill format. - 2025-09-05 05:10:00
The 6 Best Stocks to Buy Right Now in September (2025)!
My list of best stocks to buy has outperformed the broader market indexes by a significant margin. - 2025-09-04 06:00:00
The Problem With Weight Loss Stocks
In this Motley Fool Money episode, Motley Fool analysts Rick Munarriz and Karl Thiel and contributor Jason Hall dig into the problems with weight loss stocks. They also look at some investments that can survive near-term potential volatility as well as give a long-term view of di - 2025-09-03 14:48:00
NVO's Wegovy vs. LLY's Tirzepatide: Who Leads in Heart Risk Reduction?
Novo Nordisk's Wegovy shows a stronger reduction in heart risks compared to Eli Lilly's tirzepatide in real-world data from the STEER study. - 2025-09-01 11:54:00
The Zacks Analyst Blog Highlights Lilly, Oracle, Procter & Gamble and Comstock Holding Companies
Zacks spotlights Eli Lilly, Oracle, Procter & Gamble, and microcap Comstock Holding, with pharma and staples facing pressure while Oracle and Comstock show momentum. - 2025-08-29 13:58:00
Nvidia's $46.7 Billion Quarter Shows the AI Trade Is Alive and Well -- With Caveats
Key PointsWhile earnings were up 56%, the company's data center revenue dropped 1% sequentially. - 2025-08-29 05:45:00
Top Stock Reports for Eli Lilly, Oracle & Procter & Gamble
Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly, Oracle, and Procter & Gamble, as well as a micro-cap stock, Comstock. - 2025-08-28 18:59:00
2 Growth Stocks That Could Be Worth $1 Trillion in 5 Years
Key PointsEli Lilly's work in weight management should help it surpass some industry sales records. - 2025-08-28 10:45:00
2 High-Yield Dividend Stocks You Can Buy With $200 Now and Hold at Least a Decade
Key PointsDividend-paying stocks tend to outperform non-dividend-paying stocks by a mile. - 2025-08-28 04:26:00
As the Market Rotates, This Healthcare ETF Is Leading the Way
Over the past month, the market has undergone a rotation that’s seen tech sell-off and defensive sectors like healthcare reap the rewards. The jury remains out on whether this shift indicates a more inclusive rally or if it should raise questions about the bull market’s footing. - 2025-08-26 10:35:00
When AI Execs Say the Market Looks Bubbly
In this podcast, Motley Fool contributors Tyler Crowe, Lou Whiteman, and Rachel Warren discuss: - 2025-08-25 14:47:00
Eli Lilly and Company (NYSE:LLY) and Innoviva (NASDAQ:INVA) Financial Analysis
Eli Lilly and Company (NYSE:LLY – Get Free Report) and Innoviva (NASDAQ:INVA – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, risk, dividends and earnings. Institutional & Insider Ownership 82.5% of Eli […] - 2025-08-25 04:38:49
The S&P 500 Hasn't Yielded This Little Since the Dot-Com Bubble. Here's What Investors Can Do.
Key PointsThe S&P 500's rising yield is similar to what happened before the dot-com bubble burst. - 2025-08-24 15:23:00
The Best Stocks to Invest $50,000 in Right Now
Key PointsIf you have a lump sum of money, look for long-term performance and stability. - 2025-08-24 05:32:00
If I Could Only Buy 1 S&P 500 Stock From Each Sector for the Rest of 2025, I'd Go With These 11 Dividend Stocks
Key PointsSome stock market sectors significantly impact the S&P 500, whereas others barely make a dent. - 2025-08-23 19:05:00
Is the Vanguard Mega Cap ETF the Simplest Way to Invest in the Top S&P 500 Stocks?
Key PointsThe fund targets the 37% largest S&P 500 components by market cap. - 2025-08-23 17:05:00
Warren Buffett Makes a Big Buy
In this podcast, Motley Fool contributors Travis Hoium, Lou Whiteman, and Rick Munarriz discuss: - 2025-08-22 17:55:00

iShares Core S&P 500 UCITS ETF USD (Dist) LLY holdings

DateNumber of LLY Shares HeldBase Market Value of LLY SharesLocal Market Value of LLY SharesChange in LLY Shares HeldChange in LLY Base ValueCurrent Price per LLY Share HeldPrevious Price per LLY Share Held
2025-09-29 (Monday)281,750USD 204,694,193USD 204,694,193
2025-09-26 (Friday)281,750USD 204,139,145USD 204,139,145
2025-09-25 (Thursday)281,750LLY holding increased by 107USD 201,335,733LLY holding decreased by -7601127USD 201,335,733107USD -7,601,127 USD 714.59 USD 741.85
2025-09-24 (Wednesday)281,643USD 208,936,860USD 208,936,860
2025-09-18 (Thursday)280,351LLY holding increased by 106USD 213,888,188LLY holding increased by 865556USD 213,888,188106USD 865,556 USD 762.93 USD 760.13
2025-09-17 (Wednesday)280,245LLY holding increased by 106USD 213,022,632LLY holding decreased by -1202463USD 213,022,632106USD -1,202,463 USD 760.13 USD 764.71
2025-09-16 (Tuesday)280,139USD 214,225,095LLY holding increased by 4627897USD 214,225,0950USD 4,627,897 USD 764.71 USD 748.19
2025-09-15 (Monday)280,139USD 209,597,198USD 209,597,198
2025-09-12 (Friday)280,139USD 211,614,199USD 211,614,199
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of LLY by Blackrock for IE0031442068

Show aggregate share trades of LLY

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-09-25BUY107 714.590* 796.30
2025-09-18BUY106 762.930* 796.46
2025-09-17BUY106 760.130* 796.64
2025-08-19SELL-212 703.210* 798.18 Profit of 169,215 on sale
2025-08-15SELL-106 701.230* 799.19 Profit of 84,715 on sale
2025-08-13SELL-530 660.490* 799.91 Profit of 423,952 on sale
2025-08-12SELL-1,378 639.430* 800.74 Profit of 1,103,421 on sale
2025-08-07SELL-1,590 640.860* 801.57 Profit of 1,274,502 on sale
2025-08-05BUY106 765.950* 802.05
2025-07-31BUY318 740.070* 802.38
2025-07-28BUY106 808.110* 802.79
2025-07-25SELL-212 812.690* 802.73 Profit of 170,180 on sale
2025-07-24BUY106 805.430* 802.72
2025-07-22SELL-231 776.440* 802.89 Profit of 185,467 on sale
2025-07-18BUY106 771.710* 803.28
2025-07-14SELL-106 799.340* 803.80 Profit of 85,203 on sale
2025-07-08SELL-212 777.660* 804.13 Profit of 170,475 on sale
2025-07-02BUY636 779.280* 804.73
2025-06-24SELL-212 778.080* 805.36 Profit of 170,737 on sale
2025-06-23SELL-106 770.640* 805.58 Profit of 85,391 on sale
2025-06-20SELL-47 762.730* 805.84 Profit of 37,875 on sale
2025-06-12SELL-318 812.030* 806.16 Profit of 256,358 on sale
2025-06-11SELL-283 808.610* 806.14 Profit of 228,138 on sale
2025-06-06BUY106 769.880* 806.58
2025-06-02SELL-318 747.120* 807.89 Profit of 256,911 on sale
2025-05-29SELL-106 722.570* 808.95 Profit of 85,748 on sale
2025-05-27BUY106 725.220* 810.13
2025-05-23BUY106 713.710* 811.47
2025-05-21SELL-318 724.950* 812.76 Profit of 258,457 on sale
2025-05-16SELL-230 757.390* 814.05 Profit of 187,230 on sale
2025-05-15BUY424 733.290* 814.63
2025-05-14SELL-636 715.560* 815.35 Profit of 518,565 on sale
2025-05-13SELL-1,272 746.060* 815.86 Profit of 1,037,778 on sale
2025-05-07SELL-318 776.720* 817.72 Profit of 260,035 on sale
2025-05-02SELL-106 823.620* 817.98 Profit of 86,705 on sale
2025-04-29SELL-318 885.200* 816.99 Profit of 259,802 on sale
2025-04-24BUY106 859.730* 815.60
2025-04-22BUY424 827.540* 815.39
2025-04-16BUY106 734.900* 815.63
2025-04-15BUY106 757.180* 816.14
2025-04-11BUY212 732.410* 817.41
2025-04-09BUY530 753.710* 818.85
2025-04-08BUY1,590 726.240* 819.68
2025-04-07SELL-742 723.730* 820.55 Profit of 608,850 on sale
2025-04-04SELL-1,590 738.210* 821.31 Profit of 1,305,879 on sale
2025-04-02SELL-318 818.220* 821.34 Profit of 261,185 on sale
2025-04-01SELL-106 805.230* 821.49 Profit of 87,078 on sale
2025-03-31SELL-212 825.910* 821.44 Profit of 174,146 on sale
2025-03-28BUY212 822.510* 821.43
2025-03-25BUY318 852.350* 821.08
2025-03-24BUY424 864.900* 820.64
2025-03-21SELL-212 837.570* 820.47 Profit of 173,940 on sale
2025-03-20BUY212 842.570* 820.25
2025-03-19BUY424 837.010* 820.08
2025-03-17SELL-318 824.760* 820.01 Profit of 260,762 on sale
2025-03-14SELL-212 813.480* 820.07 Profit of 173,856 on sale
2025-03-13SELL-636 801.650* 820.27 Profit of 521,692 on sale
2025-03-12SELL-375 821.860* 820.25 Profit of 307,595 on sale
2025-03-11SELL-742 824.060* 820.21 Profit of 608,597 on sale
2025-03-10SELL-424 829.760* 820.11 Profit of 347,725 on sale
2025-03-06SELL-424 912.760* 818.51 Profit of 347,048 on sale
2025-03-05SELL-636 929.720* 817.25 Profit of 519,769 on sale
2025-03-04SELL-848 911.060* 816.17 Profit of 692,110 on sale
2025-02-28SELL-530 920.630* 813.60 Profit of 431,210 on sale
2025-02-26BUY212 915.010* 811.28
2025-02-24BUY212 881.400* 809.29
2025-02-21BUY106 873.680* 808.49
2025-02-20SELL-318 873.120* 807.67 Profit of 256,840 on sale
2025-02-14SELL-106 844.270* 805.24 Profit of 85,356 on sale
2025-02-13SELL-1,378 871.860* 804.34 Profit of 1,108,386 on sale
2025-02-12SELL-106 872.970* 803.40 Profit of 85,161 on sale
2025-02-06SELL-424 870.370* 799.51 Profit of 338,990 on sale
2025-02-05BUY106 842.180* 798.88
2025-02-04BUY742 826.070* 798.47
2025-01-29SELL-742 804.080* 797.60 Profit of 591,820 on sale
2025-01-28BUY212 804.990* 797.48
2025-01-24BUY106 785.410* 797.50
2025-01-22BUY212 753.980* 798.79
2025-01-16BUY212 757.600* 803.30
2025-01-15BUY106 746.740* 804.37
2025-01-10BUY212 799.900* 805.79
2025-01-02BUY318 778.070* 807.16
2024-12-31BUY212 772.000* 807.93
2024-12-27BUY106 783.170* 809.27
2024-12-20SELL-137 767.760* 811.35 Profit of 111,155 on sale
2024-12-19BUY107 757.540* 812.73
2024-12-18SELL-107 764.710* 813.99 Profit of 87,097 on sale
2024-12-17BUY214 778.620* 814.95
2024-12-13BUY107 789.120* 816.71
2024-12-11SELL-561 796.030* 817.32 Profit of 458,516 on sale
2024-12-10BUY107 799.580* 817.86
2024-12-06SELL-214 826.710* 818.03 Profit of 175,059 on sale
2024-12-05BUY107 825.620* 817.78
2024-12-04SELL-856 829.840* 817.36 Profit of 699,663 on sale
2024-12-03BUY321 813.330* 817.51
2024-12-02BUY535 799.800* 818.16
2024-11-27BUY107 788.190* 821.61
2024-11-26BUY749 789.320* 823.02
2024-11-21BUY321 749.920* 833.82
2024-11-20BUY214 753.410* 838.05
2024-11-19BUY107 729.730* 844.07
2024-11-18BUY214 727.200* 850.95
2024-11-12BUY428 818.860* 852.95
2024-11-11BUY214 832.440* 854.32
2024-11-08BUY856 831.540* 855.95
2024-11-07BUY749 797.450* 860.45
2024-11-06BUY856 776.380* 867.45
2024-11-05SELL-214 806.060* 873.03 Profit of 186,829 on sale
2024-11-04BUY214 806.140* 879.72
2024-11-01BUY749 818.930* 886.48
2024-10-28BUY535 895.590* 900.51
2024-10-25BUY1,177 892.700* 902.46
2024-10-23SELL-107 903.250* 907.64 Profit of 97,117 on sale
2024-10-21BUY107 906.130* 0.00
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of LLY

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19432,0389351,319,85332.7%
2025-09-18547,8181261,290,14742.5%
2025-09-17437,3374271,166,20437.5%
2025-09-16532,6981,8291,463,37436.4%
2025-09-15424,9797011,071,48739.7%
2025-09-12267,121172826,80232.3%
2025-09-11249,8031,484850,46129.4%
2025-09-10415,4421,025989,00842.0%
2025-09-09559,8056671,270,80044.1%
2025-09-08856,0184,6821,937,44744.2%
2025-09-05679,2761,0501,405,23948.3%
2025-09-04337,49153982,75134.3%
2025-09-03214,691496766,15728.0%
2025-09-02430,4772,9771,131,90838.0%
2025-08-29357,538602889,50940.2%
2025-08-28433,6871,0991,113,56838.9%
2025-08-27860,7156,0091,681,35351.2%
2025-08-261,548,46012,1052,955,34852.4%
2025-08-25566,4543,5861,323,24942.8%
2025-08-22749,6151,9571,460,71351.3%
2025-08-21651,6392231,570,06741.5%
2025-08-20679,5542,6981,870,24136.3%
2025-08-19787,9099352,788,74028.3%
2025-08-18756,1431,0951,727,60343.8%
2025-08-151,814,7218363,422,26053.0%
2025-08-141,852,9405,3823,602,82951.4%
2025-08-131,254,2253,4732,774,10045.2%
2025-08-12990,1103,1902,845,89634.8%
2025-08-111,290,0631,6155,196,30224.8%
2025-08-082,448,706300,8706,239,83039.2%
2025-08-074,197,951489,61810,364,29440.5%
2025-08-06440,1441,1201,811,26224.3%
2025-08-05331,460921993,17833.4%
2025-08-04474,9051,4081,273,99537.3%
2025-08-01530,5697,1391,882,09828.2%
2025-07-31882,5063,6702,110,03041.8%
2025-07-30745,6143921,827,43540.8%
2025-07-291,081,8495712,607,24541.5%
2025-07-28304,8417,4601,004,03230.4%
2025-07-25365,4172651,055,27334.6%
2025-07-24321,7997621,167,14727.6%
2025-07-23485,7193,4711,044,91946.5%
2025-07-22241,0983,036874,71727.6%
2025-07-21418,0148541,180,44535.4%
2025-07-18623,4986511,225,33350.9%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.